(BNR) Brenntag SE - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE000A1DAHH0
BNR: Chemicals, Ingredients, Blended Products, Technical
Brenntag SE is a global market leader in the distribution of industrial and specialty chemicals, operating in over 80 countries with a workforce of approximately 17,000 employees. The company provides a broad portfolio of chemicals and ingredients, supported by extensive technical and regulatory expertise, to diverse industries worldwide. Brenntags operations are divided into two core segments: Brenntag Essentials, which focuses on industrial chemicals and commodities, and Brenntag Specialties, which caters to high-value, specialized chemical solutions.
The company offers a wide range of value-added services, including custom formulation, just-in-time delivery, and supply chain optimization. Brenntags capabilities extend to repackaging, drum return handling, and digital solutions such as e-commerce platforms and product information systems. This comprehensive service offering enables customers to streamline operations and improve efficiency. Brenntag serves industries such as food and beverage, pharmaceuticals, cosmetics, water treatment, and industrial manufacturing, providing tailored solutions to meet specific application needs.
Headquartered in Essen, Germany, Brenntag was founded in 1874 and has since grown into one of the worlds largest chemical distributors. The company operates a vast network of storage facilities, distribution centers, and laboratories, ensuring proximity to customers and markets. Brenntags global presence spans Europe, North America, Latin America, Asia-Pacific, and the Middle East, with a strong focus on sustainability and safety in its operations.
3-Month Forecast: Based on
Additional Sources for BNR Stock
BNR Stock Overview
Market Cap in USD | 9,090m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
BNR Stock Ratings
Growth Rating | 13.2 |
Fundamental | 21.1 |
Dividend Rating | 92.3 |
Rel. Strength | -16.3 |
Analysts | - |
Fair Price Momentum | 54.83 EUR |
Fair Price DCF | 85.91 EUR |
BNR Dividends
Dividend Yield 12m | 6.93% |
Yield on Cost 5y | 11.98% |
Annual Growth 5y | 10.93% |
Payout Consistency | 100.0% |
BNR Growth Ratios
Growth Correlation 3m | -50.7% |
Growth Correlation 12m | -63.1% |
Growth Correlation 5y | 21.8% |
CAGR 5y | 10.24% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | -0.83 |
Alpha | -28.41 |
Beta | 0.481 |
Volatility | 32.17% |
Current Volume | 315.5k |
Average Volume 20d | 401.6k |
As of April 30, 2025, the stock is trading at EUR 57.50 with a total of 315,465 shares traded.
Over the past week, the price has changed by +3.98%, over one month by -3.52%, over three months by -3.91% and over the past year by -21.16%.
Neither. Based on ValueRay Fundamental Analyses, Brenntag SE is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 21.09 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BNR as of April 2025 is 54.83. This means that BNR is currently overvalued and has a potential downside of -4.64%.
Brenntag SE has no consensus analysts rating.
According to ValueRays Forecast Model, BNR Brenntag SE will be worth about 59.4 in April 2026. The stock is currently trading at 57.50. This means that the stock has a potential upside of +3.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 74.2 | 29% |
Analysts Target Price | - | - |
ValueRay Target Price | 59.4 | 3.3% |